Changes in Valganciclovir Use Among Infants with Congenital Cytomegalovirus Diagnosis in the United States, 2009-2015 and 2016-2019

被引：15

作者：

Leung, Jessica ^{[1
]}

Grosse, Scott D. ^{[2
]}

Hong, Kai ^{[1
]}

Pesch, Megan H. ^{[3
]}

Lanzieri, Tatiana M. ^{[1
]}

机构：

[1] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA

[2] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA

[3] Univ Michigan, Dept Pediat, Div Dev & Behav Pediat, Ann Arbor, MI 48109 USA

来源：

JOURNAL OF PEDIATRICS | 2022年 / 246卷

关键词：

CMV INFECTION; PREVALENCE;

D O I：

10.1016/j.jpeds.2022.03.042

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

From 2009-2015 to 2016-2019, the proportion of infants in the US with congenital cytomegalovirus treated with valganciclovir roughly doubled for infants enrolled with employer-sponsored insurance (from 16% to 29%) and Medicaid (from 16% to 36%). The proportion treated with valganciclovir increased for all congenital cytomegalo-virus disease severity groups.

引用

页码：274 / +

页数：7

共 22 条

[21] Results of a Targeted Screening Program for Congenital Cytomegalovirus Infection in Infants Who Fail Newborn Hearing Screening [J].

Vancor, Emily ;

Shapiro, Eugene D. ;

Loyal, Jaspreet .

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2019, 8 (01) :55-59

[22] A Legal Mapping Assessment of Cytomegalovirus-Related Laws in the United States [J].

Yassine, Brianne B. ;

Hulkower, Rachel ;

Dollard, Sheila ;

Cahill, Eric ;

Lanzieri, Tatiana .

JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, 2022, 28 (02) :E624-E629

← 1 2 3 →